Colorectal Cancer

Our medical, surgical, and radiation oncologists, gastroenterologists, and radiologists provide comprehensive, coordinated treatment and seamless care for people with even the most complex colorectal cancers, all under one roof. We personalize your treatment plan based on the location of the tumor, how advanced it is, and its molecular and genetic features.

Our clinical trials provide new and promising treatment options for people with early and more advanced colorectal cancer. NYU Langone doctors also offer high-quality colon cancer screening at convenient locations throughout the New York City area.

Clinical Trials and Research Studies

Phase 1

A Phase I First-In-Human Multicenter Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Learn More

Phase 2

A Phase 2 Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies

Learn More

Phase 1

An Open-label Multicenter Dose Escalation Phase 1b Study to Assess the Safety and Pharmacokinetics of Subcutaneous Delivery of Amivantamab a Human Bispecific EGFR and cMet Antibody for the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer

Learn More

Phase 3

A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy

Learn More